Skip to content
The Cooper Companies, Inc. logo

The Cooper Companies, Inc.

COO

The Cooper Companies, Inc. is a global medical device company that develops, manufactures, and markets products across the vision care, fertility, and women's health sectors.

Market cap
$13.85B-9.5%
Revenue$4.2B+6.1%
Net income$235.8M-43.1%
Free cash flow$569.5M+55.6%
EPS (diluted)$1.17-43.5%
Trailing twelve months · change vs. prior year

Earnings

Next report

Sep 2, 2026 (in 2 months)
Revenue estimate$1.1B
EPS estimate$1.11

Financials

Q2 2026

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation & ratios

Valuation

See full
Market cap$13.85B-9.5%
Enterprise value$16.77B-2.2%
P/E58.7×+23.4×
P/S3.3×-0.4×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Segments

By product

See full
Toric and multifocal$364.9M+11.1%
Sphere, other$358.6M+5.1%
Office and surgical$214.2M+4.1%
Fertility$143.8M+13.3%

By segment

See full
Coopervision Segment$723.5M+8.0%
Coopersurgical Segment$358.0M+7.6%

By geography

See full
Europe$341.6M+17.0%
Rest of world$192.1M-1.6%

Competitors

Profile

The Cooper Companies, Inc. is a global medical device company that develops, manufactures, and markets products across the vision care, fertility, and women's health sectors. The company operates through two primary business units, providing specialized solutions ranging from advanced contact lenses to reproductive health devices and genomic services. Its value proposition centers on elevating standards of care through technological innovation and a comprehensive portfolio that addresses both clinical and consumer healthcare needs in over 130 countries.

Competitive position

A leading global player in the contact lens market with a unique FDA-approved myopia management lens and a dominant position in the non-hormonal IUD market.

GeographiesUnited States, United Kingdom, Costa Rica, Puerto Rico, Hungary, Belgium, Netherlands, Asia Pacific, EMEA
Customer segmentsHealthcare providers, Retail consumers, Specialized medical clinics
Business modelManufacturing, Direct-to-consumer services, B2B medical supply
SuppliersPolymer chemistry suppliers, Electronic component manufacturers, Raw material suppliers for medical-grade plastics, Specialized engineering services
CustomersOptical retailers, Fertility clinic networks, Integrated delivery networks, Hospital procurement departments, Direct-to-consumer patients
Listed1983
Employees15.0K
CEOAlbert G. White
FilingsSEC EDGAR

Questions, answered.

What is The Cooper Companies, Inc.'s market cap?
The Cooper Companies, Inc. (COO) has a market capitalization of $13.9B and trades on NASDAQ.
What is The Cooper Companies, Inc.'s revenue and profitability?
The Cooper Companies, Inc. generated $4.2B in trailing twelve-month revenue with net income of $235.8M, representing a net margin of 5.6%. Gross margin stands at 65.5%, with free cash flow of $569.5M. These figures are based on the Q2 2026 filing.
Who are The Cooper Companies, Inc.'s competitors?
The Cooper Companies, Inc.'s key competitors include Bausch + Lomb, Johnson & Johnson Vision Care, Inc., Medtronic, and others. These companies compete in similar markets and product categories.
Where is The Cooper Companies, Inc. headquartered?
The Cooper Companies, Inc. is headquartered in United States of America and employs approximately 15,000 people. It has been publicly traded since 1983.